Whitehawk Therapeutics, Inc. Common Stock WHWK Income Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| $7.15M-72.5% | $25.98M+6.7% | $24.35M— | ||
| $760K-74.9% | $3.02M+7.7% | $2.81M— | ||
| $6.39M-72.2% | $22.96M+6.6% | $21.55M— | ||
| 89.4%+1.0pp | 88.4%-0.1pp | 88.5%— | ||
| $90.96M+78.3% | $51.03M+4.3% | $48.93M— | ||
| $29.82M-18.8% | $36.75M-17.5% | $44.55M— | ||
| $121.55M+30.1% | $93.44M-3.0% | $96.29M— | ||
| -$114.4M-69.6% | -$67.46M+6.2% | -$71.93M— | ||
| -1,601.1%-1,341pp | -259.6%+35.7pp | -295.4%— | ||
| $93.8M+2,390% | $3.77M-38.9% | $6.17M— | ||
| —— | -$63.69M— | —— | ||
| —— | $0— | —— | ||
| -$20.6M+67.7% | -$63.69M+3.2% | -$65.77M— | ||
| -288.3%-43.1pp | -245.1%+24.9pp | -270%— | ||
| $0.44+119% | -$2.36+3.3% | -$2.44— | ||
| -$114.32M-70.0% | -$67.26M+6.3% | -$71.76M— | ||
| -1,600%-1,341pp | -258.9%+35.8pp | -294.7%— | ||
| -$114.4M-69.6% | -$67.46M+6.2% | -$71.93M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Whitehawk Therapeutics, Inc. Common Stock profitable?
- Whitehawk Therapeutics, Inc. Common Stock is not currently profitable: it reported a net loss of $115.8M over the trailing twelve months, a -288.3% net margin.
- What are Whitehawk Therapeutics, Inc. Common Stock's profit margins?
- Gross margin is 89.4% and operating margin is -1601.1%, with a -288.3% net margin.
- What is Whitehawk Therapeutics, Inc. Common Stock's earnings per share?
- Whitehawk Therapeutics, Inc. Common Stock's diluted EPS over the trailing twelve months is $-1.71.
- Where does Whitehawk Therapeutics, Inc. Common Stock's income statement data come from?
- Every line is extracted from Whitehawk Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.